Clinical Trials Directory

Trials / Completed

CompletedNCT05284890

A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants

A Phase 1, Single-center, Open-label Study to Evaluate the Metabolism and Excretion of [14C]CC-99677 in Healthy Male Participants

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
8 (actual)
Sponsor
Bristol-Myers Squibb · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to characterize the absorption, distribution, metabolism and excretion (ADME) of a single oral dose of \[14C\] CC-99677.

Conditions

Interventions

TypeNameDescription
DRUGCC-99677Specified dose on specified days

Timeline

Start date
2022-05-12
Primary completion
2022-07-11
Completion
2022-07-11
First posted
2022-03-17
Last updated
2022-12-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05284890. Inclusion in this directory is not an endorsement.

A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants (NCT05284890) · Clinical Trials Directory